| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6710487
[patent_doc_number] => 20030170236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'IDENTIFICATION AND USE OF HIGH EFFICACY VACCINE ANTIGENS WHICH MODULATE ANTIGEN PRESENTING CELLS'
[patent_app_type] => new
[patent_app_number] => 09/313487
[patent_app_country] => US
[patent_app_date] => 1999-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14174
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170236.pdf
[firstpage_image] =>[orig_patent_app_number] => 09313487
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/313487 | Identification of candidate ligands which modulate antigen presenting cells | May 16, 1999 | Issued |
| 09/312393 | MECHANISM FOR THE INACTIVATION OF INSULIN RECEPTOR AND USES IN THE TREATMENT OF TYPE II DIABETES | May 13, 1999 | Abandoned |
| 09/310325 | IMMUNOTHERAPY OF A CANCER WITH ALLOGENEIC LYMPHOCYTES | May 11, 1999 | Abandoned |
| 09/309881 | TARGETING OF LANGERHANS CELLS AND OTHER ANTIGEN PRESENTING CELLS IN SKIN TO ENHANCE TRANSCUTANEOUS IMMUNIZATION | May 10, 1999 | Abandoned |
Array
(
[id] => 6860571
[patent_doc_number] => 20030091579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'METHODS OF RAISING ANIMALS FOR MEAT PRODUCTION'
[patent_app_type] => new
[patent_app_number] => 09/305924
[patent_app_country] => US
[patent_app_date] => 1999-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18843
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091579.pdf
[firstpage_image] =>[orig_patent_app_number] => 09305924
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/305924 | METHODS OF RAISING ANIMALS FOR MEAT PRODUCTION | May 4, 1999 | Abandoned |
| 09/291712 | METHODS RELATED TO THE COMBINED USE OF IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION | Apr 13, 1999 | Abandoned |
| 09/282679 | IN VITRO INDUCTION OF ANTIGEN-SPECIFIC T-CELLS USING DENDRITIC CELL-TUMOR CELL OR DENDRITIC CELL-VIRAL CELL DERIVED IMMUNOGENS | Mar 30, 1999 | Abandoned |
| 09/254825 | PEPTIDE AS DIAGNOSTIC AND THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES | Mar 11, 1999 | Abandoned |
Array
(
[id] => 731467
[patent_doc_number] => 07037499
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Adjuvant for transcutaneous immunization'
[patent_app_type] => utility
[patent_app_number] => 09/266803
[patent_app_country] => US
[patent_app_date] => 1999-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 17410
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037499.pdf
[firstpage_image] =>[orig_patent_app_number] => 09266803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/266803 | Adjuvant for transcutaneous immunization | Mar 11, 1999 | Issued |
Array
(
[id] => 1118682
[patent_doc_number] => 06797269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-28
[patent_title] => 'Mesenchymal stem cells as immunosuppressants'
[patent_app_type] => B2
[patent_app_number] => 09/267456
[patent_app_country] => US
[patent_app_date] => 1999-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 4156
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797269.pdf
[firstpage_image] =>[orig_patent_app_number] => 09267456
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/267456 | Mesenchymal stem cells as immunosuppressants | Mar 11, 1999 | Issued |
Array
(
[id] => 1153687
[patent_doc_number] => 06764688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-20
[patent_title] => 'Method for inducing immunosuppressive cells and a culture device to be used therefor'
[patent_app_type] => B2
[patent_app_number] => 09/254170
[patent_app_country] => US
[patent_app_date] => 1999-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 6236
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/764/06764688.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254170
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254170 | Method for inducing immunosuppressive cells and a culture device to be used therefor | Mar 1, 1999 | Issued |
Array
(
[id] => 691373
[patent_doc_number] => 07074888
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-11
[patent_title] => 'Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX'
[patent_app_type] => utility
[patent_app_number] => 09/258947
[patent_app_country] => US
[patent_app_date] => 1999-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 14
[patent_no_of_words] => 12366
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074888.pdf
[firstpage_image] =>[orig_patent_app_number] => 09258947
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/258947 | Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX | Feb 28, 1999 | Issued |
Array
(
[id] => 4407261
[patent_doc_number] => 06228599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Antibody specific for homogalacturonan'
[patent_app_type] => 1
[patent_app_number] => 9/260527
[patent_app_country] => US
[patent_app_date] => 1999-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 9779
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228599.pdf
[firstpage_image] =>[orig_patent_app_number] => 260527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/260527 | Antibody specific for homogalacturonan | Feb 25, 1999 | Issued |
| 09/258553 | ANIMAL SERUM PRODUCT FOR GUT MUCOSAL PROECTION AND PREVENTION OF INFECTION BY VEROTOXIN-PRODUCING ORGANISMS | Feb 25, 1999 | Abandoned |
Array
(
[id] => 1118723
[patent_doc_number] => 06797276
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-28
[patent_title] => 'Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response'
[patent_app_type] => B1
[patent_app_number] => 09/257188
[patent_app_country] => US
[patent_app_date] => 1999-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 26572
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797276.pdf
[firstpage_image] =>[orig_patent_app_number] => 09257188
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/257188 | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response | Feb 24, 1999 | Issued |
Array
(
[id] => 1523221
[patent_doc_number] => 06352697
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => 'Saponin preparations and use thereof in iscoms'
[patent_app_type] => B1
[patent_app_number] => 08/809987
[patent_app_country] => US
[patent_app_date] => 1999-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 6272
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/352/06352697.pdf
[firstpage_image] =>[orig_patent_app_number] => 08809987
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/809987 | Saponin preparations and use thereof in iscoms | Feb 21, 1999 | Issued |
Array
(
[id] => 6765254
[patent_doc_number] => 20030099652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'NOVEL HUMAN PROTEIN TYROSINE KINASE'
[patent_app_type] => new
[patent_app_number] => 09/251225
[patent_app_country] => US
[patent_app_date] => 1999-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15692
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099652.pdf
[firstpage_image] =>[orig_patent_app_number] => 09251225
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/251225 | NOVEL HUMAN PROTEIN TYROSINE KINASE | Feb 15, 1999 | Abandoned |
Array
(
[id] => 1374777
[patent_doc_number] => 06558951
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-06
[patent_title] => 'Maturation of dendritic cells with immune response modifying compounds'
[patent_app_type] => B1
[patent_app_number] => 09/248439
[patent_app_country] => US
[patent_app_date] => 1999-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 10956
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/558/06558951.pdf
[firstpage_image] =>[orig_patent_app_number] => 09248439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/248439 | Maturation of dendritic cells with immune response modifying compounds | Feb 10, 1999 | Issued |
Array
(
[id] => 7634570
[patent_doc_number] => 06657049
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Fatty acid transport proteins'
[patent_app_type] => B1
[patent_app_number] => 09/232195
[patent_app_country] => US
[patent_app_date] => 1999-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 170
[patent_figures_cnt] => 202
[patent_no_of_words] => 82181
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/657/06657049.pdf
[firstpage_image] =>[orig_patent_app_number] => 09232195
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/232195 | Fatty acid transport proteins | Jan 13, 1999 | Issued |
| 09/218539 | COMPOSITIONS AND METHODS FOR GENERATING MONOCLONAL ANTIBODIES REPRESENTATIVE OF A SPECIFIC CELL TYPE | Dec 21, 1998 | Abandoned |
